Skip to main content
. Author manuscript; available in PMC: 2009 Dec 1.
Published in final edited form as: Biochem Pharmacol. 2008 Sep 20;76(11):1383–1388. doi: 10.1016/j.bcp.2008.09.017

TABLE 3.

In vivo blockade of C5a after CLP

1. Improved survival
2. Reduced loss of innate immune function of blood PMNs
3. Alleviation of the cardiomyopathy of sepsis
4. Greatly diminished apoptosis of thymocytes
5. Attenuation of consumptive coagulopathy of sepsis